Schedule 13G ownership disclosure

Akebia Therapeutics Inc

Security class unavailable · CUSIP: 00972D105

Event date: 2017-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,933,867
Percent of class
4.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-008432
Form type
SC 13G/A
Filer
Akebia Therapeutics, Inc.
CIK
CIK 1517022
Filed
Feb 14, 2018
Reporting period
Dec 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub